Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-007713

SVP & Chief Accounting Officer sold 37,500 shares at $22.78 ($854,250)

  • SVP & Chief Accounting Officer acquired 37,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2020-02-06 Option exercise +37,500 $7.21 $270,375 212,980 D
Thomsen Jillian B. SVP & Chief Accounting Officer 2020-02-06 Sale −37,500 $22.78 $854,250 175,480 D
Derivatives
Thomsen Jillian B. SVP & Chief Accounting Officer 2020-02-06 Option exercise · Stock Option −37,500 0 D
Open-market sales · 37,500 sh · avg $22.78 · $854,250
Loading xslF345X03/doc4.xml…